高端疫苗

-2.60 (-4.23%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

58.807,604成交張數–本益比5.44股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	48	36	25.3%	22.37	10.81	-4.6%	-3.8%	-0.9	-1.0
2026Q1	48	35	26.4%	15.32	10.71	-7.9%	-6.4%	-0.6	-1.6
2025Q4	39	35	11.6%	12.77	10.58	-7.7%	-6.8%	1.0	1.0
2025Q3	41	36	11.3%	14.12	10.97	-4.4%	-4.0%	-0.1	-0.4
2025Q2	41	37	11.4%	13.70	11.15	-3.8%	-3.4%	-0.7	-0.8
2025Q1	43	38	11.6%	12.61	11.47	-0.7%	-0.5%	-0.7	-0.8
2024Q4	44	38	11.8%	11.94	11.71	-2.1%	-1.5%	1.7	1.7
2024Q3	43	39	10.6%	12.69	11.74	-15.5%	-11.7%	0.0	-0.1
2024Q2	43	38	10.7%	11.99	11.70	-16.6%	-12.7%	-1.4	-1.5
2024Q1	59	38	36.4%	2.19	11.49	-23.8%	-15.8%	0.1	-0.0
2023Q4	61	38	36.9%	2.21	11.71	-26.1%	-17.3%	0.3	0.2
2023Q3	66	44	33.3%	2.53	13.44	-25.5%	-17.8%	-1.1	-1.1
2023Q2	67	45	32.4%	2.59	13.70	-30.0%	-20.8%	-3.5	-3.5
2023Q1	70	48	31.0%	26.39	14.68	-32.9%	-25.3%	-0.5	-0.7
2022Q4	73	50	31.6%	15.38	15.34	-30.4%	-23.3%	0.9	0.8
2022Q3	80	57	28.1%	21.85	17.52	6.6%	5.0%	-5.4	-5.5
2022Q2	83	59	29.0%	14.12	27.47	29.7%	21.0%	-6.0	-6.2
2022Q1	52	46	12.1%	9.72	21.57	37.5%	32.8%	-0.5	-0.5
2021Q4	53	47	11.8%	8.48	21.97	36.1%	32.1%	10.0	9.3
2021Q3	45	36	19.6%	4.20	16.86	6.3%	4.7%	-1.8	-2.0
2021Q2	41	29	30.3%	2.44	13.52	-32.0%	-21.9%	-0.9	-1.0
2021Q1	35	30	12.8%	7.58	14.30	-29.6%	-23.4%	-1.5	-1.7
2020Q4	35	31	10.0%	12.48	14.88	-29.9%	-23.4%	-1.3	-1.4
2020Q3	22	14	36.9%	2.63	7.51	-51.9%	-31.6%	-1.7	-1.8
2020Q2	23	15	34.2%	3.88	8.22	-43.4%	-27.5%	-1.5	-1.6
2020Q1	25	17	32.2%	5.15	9.13	-38.4%	-25.2%	-1.5	-1.6
2019Q4	23	14	40.0%	2.28	8.76	-41.5%	-27.7%	-1.0	-1.6
2019Q3	21	12	41.5%	2.16	7.76	-39.6%	-26.9%	-0.4	-0.7
2019Q2	22	13	39.3%	3.55	8.54	-34.9%	-24.1%	-1.1	-1.2
2019Q1	23	15	36.8%	5.24	9.54	–	–	-2.2	-2.3
2018Q4	22	16	26.2%	5.62	10.37	–	–	-1.2	-1.2
2018Q3	23	18	23.7%	9.22	11.40	–	–	-0.8	-0.8
2018Q2	24	19	23.4%	10.20	12.00	–	–	–	–